Epicelya Therapeutics

Biotechnology Research • • 1-10 Employees

Company overview

Headquarters	XX
Website	epicelya.com
NAICS	541714
Employees	1-10

Key Contact at Epicelya Therapeutics

Sara Laudato

CSO & Co-founder

About Epicelya Therapeutics

Epicelya Therapeutics is a precision medicine company pioneering the future of genetic healthcare. Our mission is to develop mRNA-based therapeutics that target diseases previously considered "undruggable". Through our innovative precision epigenetics and targeted cell elimination platforms, we aim to address the most challenging conditions, especially where traditional treatments have failed or lack suitable targets, with a focus on oncology and age-related diseases. Based in Basel, Switzerland’s pharma-biotech hub, we are at the heart of scientific innovation. Learn more at www.epicelya.com.

Epicelya Therapeutics revenue & valuation

Annual revenue	$85,555
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$273,776
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Epicelya Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Epicelya Therapeutics has never raised funding before.